Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robust methods in bioequivalence assay; preliminary results

A V Niselman1, M Garcia Ben, M C Rubio

  • 1Department of Mathematics, Faculty of Pharmacy and Biochemistry, Buenos Aires, Argentina.

European Journal of Drug Metabolism and Pharmacokinetics
|September 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety cost management in construction companies: A proposal classification.

Work (Reading, Mass.)·2016
Same author

Relation between periodontal disease and arterial stiffness.

Journal of periodontal research·2016
Same author

Chronic administration of valproic acid induces a decrease in rat striatal glutamate and taurine levels.

Amino acids·2013
Same author

Cavitary pneumonia caused by Nocardia otitidiscaviarum.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2013
Same author

Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus D+/R-) liver transplant recipients: a single-center experience.

Transplantation proceedings·2009
Same author

Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing.

Revista iberoamericana de micologia·2008

Robust statistical methods effectively identify outliers in bioequivalence (BE) studies, unlike traditional parametric approaches. These robust methods ensure accurate bioequivalence conclusions even with outlier data.

Area of Science:

  • Pharmacometrics
  • Statistical analysis
  • Drug development

Background:

  • Bioequivalence (BE) studies are crucial for generic drug approval.
  • Accurate outlier identification is essential for reliable BE assessment.
  • Traditional parametric methods may be sensitive to outliers, potentially affecting BE conclusions.

Purpose of the Study:

  • To compare the performance of four statistical methods for outlier identification in BE tests.
  • To evaluate parametric, non-parametric, and two robust methods.
  • To assess method efficacy using simulated and experimental data for Diltiazem.

Main Methods:

  • Four confidence interval-based methods were compared: parametric, non-parametric, robust (M-estimator), and robust (bootstrap).
  • Simulations included normal data and data with outliers.

Related Experiment Videos

  • Experimental data from a Diltiazem randomized crossover study measuring AUC and CMAX were analyzed.

    • Main Results:

    • All methods performed similarly with normal data, showing high power.
    • Parametric methods exhibited low power with outlier data, while robust methods showed only a slight decrease.
    • Parametric analysis of experimental AUC data failed to conclude bioequivalence, unlike robust methods, indicating the presence of outliers.

    Conclusions:

    • Robust statistical methods are superior for outlier detection in bioequivalence assays.
    • Robust methods facilitate the identification of outliers, assigning them zero weight.
    • These findings support the use of robust methods for more reliable bioequivalence assessments.